ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1049

The Prevalence of the Ultrasonographic Positive Power Doppler Synovitis Is High and Predicts the Risk of Relapse and Structural Progression in Rheumatoid Arthritis in Clinical Remission: A Systematic Literature Review and Meta Analysis

Huong Nguyen1, Adeline Ruyssen-Witrand1, Arnaud L. Constantin1, Violaine Foltz2, Frédérique Gandjbakhch3 and Alain G. Cantagrel1, 1Rheumatology, Purpan University Hospital, Toulouse, France, 2APHP, Pitié Salpétrière Hospital, Universite Paris 6, Paris, France, 3Department of Rheumatology, APHP, Pitié Salpétrière Hospital, Universite Paris 6, Paris, France

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: prognostic factors, remission, Rheumatoid arthritis (RA), synovitis and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging, Computed Tomography and X-ray

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Ultrasonography (US) can detect synovitis in patients with rheumatoid arthritis (RA) more sensitively than clinical examination either in active disease or in remission.1, 2 There are many definitions of clinical remission, no consensus on US assessment of RA activity and the clinical implication of residual US synovitis is hotly debated.3, 4 This study is to assess the prevalence of residual US synovial hypertrophy (USGS+) and US power Doppler (PD) activity in patients in clinical remission and evaluate the predictive value of this residual synovitis in terms of relapse and structural progression.

Methods:

A systematic literature search was performed in the Medline, Embase and Rheumatology meeting databases up to 28 May 2012. The prevalence of USGS+, cold synovitis (USGS+/PD-), active synovitis (USGS+/PD+) and complete remission (USGS-/PD-) were collected taking into account the definition of clinical remission, the stage of RA (early or established disease) and the US examination method. A meta-analysis assessing the risk of relapse or structural progression in patients with USGS+/PD+ compared to other patients was performed calculating the odds ratio (ORMH) and 95% confidence interval [95%CI] with the Mantel-Haenszel method.

Results:

18 studies including 1528 patients were included in this systematic literature review. All of the studies used the OMERACT method for US scoring. The prevalence of US GS+, USGS+/PD-, USGS+/PD+ and USGS-/PD- were 81.8 %, 40%, 43% and 15.7%, respectively. USGS+ or USGS+/PD+ prevalence was comparable between the different definitions of clinical remission (DAS44, DAS28, SDAI, ACR 1981 or ACR/EULAR 2011) and between the different US examination methods (from 5 to 44 joints assessed). The prevalence of USGS+ and USGS+/PD+ was higher in the patients with established RA in comparison to patients with early RA (respectively 87% of USGS+ compared to 64%, p<0.001 and 45% of USGS+/PD+ compared to 34%, p<0.001). According to the results of the meta-analysis performed on 4 studies5-8 (including 178 patients) and 3 studies5, 9, 10 (including 173 patients), the presence of USGS+/PD+ was associated with an increased risk of relapse (ORMH[95%CI]=2.9, [1.5,5.9], p=0.002) and an increased risk of structural progression (OR[95%CI]= 12.8, [1.3, 126.8], p=0.03), respectively, over 1 to 2 years.

Conclusion:

The prevalence of residual US synovitis is high in patients in clinical remission. Residual USGS+/PD+ increase the risk of relapse and structural progression in these patients.


Disclosure:

H. Nguyen,
None;

A. Ruyssen-Witrand,
None;

A. L. Constantin,
None;

V. Foltz,
None;

F. Gandjbakhch,
None;

A. G. Cantagrel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-prevalence-of-the-ultrasonographic-positive-power-doppler-synovitis-is-high-and-predicts-the-risk-of-relapse-and-structural-progression-in-rheumatoid-arthritis-in-clinical-remission-a-systematic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology